Large-scale ex vivo expansion and characterization of natural killer cells for clinical applications-Reference-Cited by-同舟云学术

Large-scale ex vivo expansion and characterization of natural killer cells for clinical applications

Published:2012-09 Issue:9 Volume:14 Page:1131-1143
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Lapteva Natalia,Durett April G.,Sun Jiali,Rollins Lisa A.,Huye Leslie L.,Fang Jian,Dandekar Varada,Mei Zhuyong,Jackson Kimberley,Vera Juan,Ando Jun,Ngo Minhtran C.,Coustan-Smith Elaine,Campana Dario,Szmania Susann,Garg Tarun,Moreno-Bost Amberly,Vanrhee Frits,Gee Adrian P.,Rooney Cliona M.

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics(clinical),Oncology,Immunology,Immunology and Allergy

Reference38 articles.

1. Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population;Imai;Lancet,2000

2. Evaluation of natural killer cell activity in pre and post treated breast cancer patients;Piroozmand;J Cancer Res Ther,2010

3. Natural killer activity of peripheral-blood mononuclear cells in breast cancer patients;Dewan;Biomed Pharmacother,2009

4. Preoperative natural killer cell activity as a prognostic factor for distant metastasis following surgery for colon cancer;Kondo;Dig Surg,2003

5. Clinical impact of intratumoral natural killer cell and dendritic cell infiltration in gastric cancer;Ishigami;Cancer Lett,2000

Cited by 164 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Artificial antigen-presenting cells: the booster for the obtaining of functional adoptive cells;Cellular and Molecular Life Sciences;2024-08-31

2. Beyond CAR-T: The rise of CAR-NK cell therapy in asthma immunotherapy;Journal of Translational Medicine;2024-08-05

3. The Spectrum of CAR Cellular Effectors: Modes of Action in Anti-Tumor Immunity;Cancers;2024-07-22

4. A review and statistical analysis to identify and describe relationships between CQAs and CPPs of natural killer cell expansion processes;Cytotherapy;2024-06

5. IL-15 as a key regulator in NK cell-mediated immunotherapy for cancer: From bench to bedside;International Immunopharmacology;2024-05